Cargando...
ELF3 Overexpression as Prognostic Biomarker for Recurrence of Stage II Colorectal Cancer
Background/Aim: Adjuvant chemotherapy for high-risk Stage II colorectal cancer (CRC) is weakly recommended; however, no consensus exists on “high-risk” definition. Prognostic biomarker identification is important for selecting patients with poor prognosis who may benefit from adjuvant chemotherapy....
Guardado en:
| Publicado en: | In Vivo |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
International Institute of Anticancer Research
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880722/ https://ncbi.nlm.nih.gov/pubmed/33402466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12248 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|